Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

October 01, 1993; Volume 267,Issue 1

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 566;
  • You have access
    The discriminative stimulus effects of cocaine in pigeons.
    C E Johanson and J E Barrett
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 1-8;
  • You have access
    Immune alterations in morphine-treated rhesus monkeys.
    D J Carr and C P France
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 9-15;
  • You have access
    Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    F P Bymaster, I Heath, J C Hendrix and H E Shannon
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 16-24;
  • You have access
    Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
    C E Ohrnberger, S A Khan and K D Meisheri
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 25-30;
  • You have access
    Platelet-activating factor (PAF) induces a contraction of isolated smooth muscle cells from guinea pig ileum: intracellular pathway involved.
    O Jeanneton, M Delvaux, A Botella, J Frexinos and L Bueno
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 31-37;
  • You have access
    Age-related changes in norepinephrine release and its modulation by presynaptic alpha-2 adrenoceptors in the rat vas deferens.
    M C de Avellar and R P Markus
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 38-44;
  • You have access
    Serotonergic modulation of L-glutamic acid-evoked release of endogenous norepinephrine from rat hypothalamus.
    J Goldfarb, J Walcott and P Blandina
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 45-50;
  • You have access
    BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
    R Müller-Peddinghaus, C Kohlsdorfer, P Theisen-Popp, R Fruchtmann, E Perzborn, B Beckermann, K Bühner, H J Ahr and K H Mohrs
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 51-57;
  • You have access
    Preclinical studies on LY228729: a potent and selective serotonin1A agonist.
    M M Foreman, R W Fuller, J D Leander, M J Benvenga, D T Wong, D L Nelson, D O Calligaro, S P Swanson, J B Lucot and M E Flaugh
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 58-71;
  • You have access
    Potassium channel blockade and halothane vasodilation in conducting and resistance coronary arteries.
    D R Larach and H G Schuler
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 72-81;
  • You have access
    Prolactin increases Na+/taurocholate cotransport in isolated hepatocytes from postpartum rats and ovariectomized rats.
    T Ganguly, J F Hyde and M Vore
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 82-87;
  • You have access
    Neuropeptide FF receptors: structure-activity relationship and effect of morphine.
    K Payza, C A Akar and H Y Yang
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 88-94;
  • You have access
    Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster.
    J L Ellis, B J Undem, J S Kays, S V Ghanekar, H G Barthlow and C K Buckner
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 95-101;
  • You have access
    Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
    G J Grover, P G Sleph, S Dzwonczyk and J R McCullough
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 102-107;
  • You have access
    Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
    N C Trippodo, M Fox, V Natarajan, B C Panchal, C R Dorso and M M Asaad
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 108-116;
  • You have access
    Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice.
    R M Quock, B A Curtis, B J Reynolds and J L Mueller
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 117-122;
  • You have access
    Effects of antimycin A on the binding properties of beta and alpha-1 adrenergic receptors measured on intact cells.
    S J Zhu and M L Toews
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 123-127;
  • You have access
    Role of signal transduction systems in neurotensin receptor down-regulation induced by agonist in murine neuroblastoma clone N1E-115 cells.
    M Yamada, M Yamada and E Richelson
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 128-133;
  • You have access
    Effect of chronic neuroleptic treatment on central and peripheral muscarinic receptors.
    T A Cawley, T J Shickley, M R Ruggieri and G R Luthin
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 134-139;
  • You have access
    Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
    X J Xu, J X Hao, A Seiger and Z Wiesenfeld-Hallin
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 140-144;
  • You have access
    Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
    S Izenwasser, B Búzás and B M Cox
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 145-152;
  • You have access
    Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system.
    S R Tella, C W Schindler and S R Goldberg
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 153-162;
  • You have access
    Anticonvulsant and related effects of U-54494A in various seizure tests.
    W Fischer, R Bodewei, P F VonVoigtlander and M Müller
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 163-170;
  • You have access
    Localization of a defect in hypothalamic dopaminergic neurons of the aged brain that results in impaired PKA-dependent activation of tyrosine hydroxylase.
    N Aguila-Mansilla, W Kedzierski and J C Porter
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 171-175;
  • You have access
    Calcium modulation and cell injury in isolated rat proximal tubules.
    J F Wetzels, L Yu, X Wang, A Kribben, T J Burke and R W Schrier
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 176-180;
  • You have access
    Inhibition of methylphenidate-induced behaviors in rats: differences among neuroleptics.
    W Koek and F C Colpaert
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 181-191;
  • You have access
    (+-)-Methyl-2,3,3a,4-tetrahydro-1H-indolo [3,2,1-de] [1,5] naphthyridine-6-carboxylate monohydrochloride facilitates phosphatidylinositol hydrolysis: possible involvement of muscarinic and nonmuscarinic mechanisms.
    M Katsura, T Iino and K Kuriyama
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 192-196;
  • You have access
    Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
    D R Kapusta and J C Obih
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 197-204;
  • You have access
    Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
    A N Schoffelmeer, T J De Vries, F Hogenboom and A H Mulder
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 205-210;
  • You have access
    Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals.
    K Xu, L Näveri, K U Frerichs, J M Hallenbeck, G Feuerstein, J N Davis and A L Sirén
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 211-217;
  • You have access
    Phenytoin blocks N-methyl-D-aspartate responses of mouse central neurons.
    A W Wamil and M J McLean
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 218-227;
  • You have access
    Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptors.
    R E Purdy, B A Prins, M A Weber, A Bakhtiarian, J R Smith, M K Kim, T H Nguyen and E W Weiler
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 228-237;
  • You have access
    Naltrexone-induced upregulation of mu opioid receptors on 7315c cell and brain membranes: enhancement of opioid efficacy in inhibiting adenylyl cyclase.
    T E Côté, S Izenwasser and H B Weems
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 238-244;
  • You have access
    The effects of the potent glucocorticoid budesonide on adhesion of eosinophils to human vascular endothelial cells and on endothelial expression of adhesion molecules.
    J Kaiser, C A Bickel, B S Bochner and R P Schleimer
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 245-249;
  • You have access
    Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants.
    F Weiss, M T Lorang, F E Bloom and G F Koob
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 250-258;
  • You have access
    Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2-versus 3-series prostanoid generation.
    F Grimminger, K Mayer, H J Krämer, J Stevens, D Walmrath and W Seeger
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 259-265;
  • You have access
    Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
    J M Witkin, A H Newman, G Nowak and J L Katz
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 266-274;
  • You have access
    Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys.
    P Blanchet, P J Bédard, D R Britton and J W Kebabian
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 275-279;
  • You have access
    Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
    E A Walker, E R Butelman, B R DeCosta and J H Woods
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 280-286;
  • You have access
    Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.
    R L Webb, M A Sills, J P Chovan, J V Peppard and J E Francis
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 287-295;
  • You have access
    Effects of cocaine alone and in combination with mazindol in human cocaine abusers.
    K L Preston, J T Sullivan, P Berger and G E Bigelow
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 296-307;
  • You have access
    Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectomy or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen.
    G K De Krey, L Baecher-Steppan, J A Deyo, B Smith and N I Kerkvliet
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 308-315;
  • You have access
    Mechanism of ochratoxin A-induced reduction of glomerular filtration rate in rats.
    M Gekle and S Silbernagl
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 316-321;
  • You have access
    Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
    E A Walker and A M Young
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 322-330;
  • You have access
    Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
    R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd, J L Vaught, H I Jacoby and N Selve
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 331-340;
  • You have access
    Multiple spinal mediators in parenteral nicotine-induced antinociception.
    D T Rogers and E T Iwamoto
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 341-349;
  • You have access
    Characterization of [125I][Ser1]histogranin binding sites in rat brain.
    C Rogers and S Lemaire
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 350-356;
  • You have access
    Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets.
    D G Levier, R D Brown, J A McCay, B A Fuchs, L S Harris and A E Munson
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 357-363;
  • You have access
    Urea transport in toad skin (Bufo marinus)
    G Dytko, P L Smith and L B Kinter
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 364-370;
  • You have access
    Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
    L Jia and R F Furchgott
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 371-378;
  • You have access
    [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
    N H Chen and M E Reith
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 379-389;
  • You have access
    Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?
    S P Welch and L D Dunlow
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 390-399;
  • You have access
    Modulation of superoxide anion generation by manoalide, arachidonic acid and staurosporine in liver infiltrated neutrophils in a rat model of endotoxemia.
    A M Mayer and J A Spitzer
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 400-409;
  • You have access
    ATP-sensitive potassium channels and skeletal muscle function in vitro.
    E O Weselcouch, C Sargent, M W Wilde and M A Smith
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 410-416;
  • You have access
    Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats.
    M G Henderson, K W Perry and R W Fuller
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 417-424;
  • You have access
    Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration.
    K Yeleswaram, D W Rurak, E Kwan, C Hall, A Doroudian, M R Wright, F S Abbott and J E Axelson
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 425-431;
  • You have access
    Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey.
    L L Howell and L D Byrd
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 432-439;
  • You have access
    Nicotinic agonists modulate basal forebrain control of cortical cerebral blood flow in anesthetized rats.
    D G Linville, S Williams, J L Raszkiewicz and S P Arneric
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 440-448;
  • You have access
    Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.
    T W Vanderah, K D Wild, A E Takemori, M Sultana, P S Portoghese, W D Bowen, V J Hruby, H I Mosberg and F Porreca
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 449-455;
  • You have access
    Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs.
    H Takagi, A Takahara, Y Tomura, T Yamagata, H Hisa and S Satoh
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 456-461;
  • You have access
    Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex.
    E Romeo, S Cavallaro, A Korneyev, A P Kozikowski, D Ma, A Polo, E Costa and A Guidotti
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 462-471;
  • You have access
    Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
    S McLean, A Ganong, P A Seymour, R M Snider, M C Desai, T Rosen, D K Bryce, K P Longo, L S Reynolds and G Robinson
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 472-479;
  • You have access
    Use of m1-toxin as a selective antagonist of m1 muscarinic receptors.
    S I Max, J S Liang, H H Valentine and L T Potter
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 480-485;
  • You have access
    Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine.
    P W Kalivas and J E Alesdatter
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 486-495;
  • You have access
    Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems.
    R V Bhat and J M Baraban
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 496-505;
  • You have access
    Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections.
    T J Martin, S I Dworkin and J E Smith
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 506-514;
  • You have access
    Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats.
    G Apseloff, B Girten, S E Weisbrode, M Walker, L S Stern, M E Krecic and N Gerber
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 515-521;
  • You have access
    Molecular basis for regionally specific action of ethanol on gamma-aminobutyric acidA receptors: generalization to other ligand-gated ion channels.
    H E Criswell, P E Simson, G E Duncan, T J McCown, J S Herbert, A L Morrow and G R Breese
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 522-537;
  • You have access
    On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice.
    S J Kanes, B A Hitzemann and R J Hitzemann
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 538-547;
  • You have access
    Duration and dose-related effects of an orally administered, partially lipophilic polyaminocarboxylic acid on the decorporation of plutonium and americium.
    S C Miller, F W Bruenger, G Kuswik-Rabiega, G Liu and R D Lloyd
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 548-554;
  • You have access
    Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization.
    S Bhamre, S V Bhagwat, S K Shankar, D E Williams and V Ravindranath
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 555-559;
  • You have access
    Ethanol consumption by the nursing mother induces cytochrome P-4502E1 in neonatal rat liver.
    D Wu and A I Cederbaum
    Journal of Pharmacology and Experimental Therapeutics October 1993, 267 (1) 560-566;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 267, Issue 1
1 Oct 1993
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Read
Loading
  • Smoking Could Worsen COVID-19 Outcome
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Potential Clinical Uses of CBG
  • Nose-to-Brain Delivery
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics